The National Disease Research Interchange (NDRI) has been included in the Philadelphia Business Journal’s annual Book of Lists, as one of the largest National Institutes of Health (NIH) funding recipients in the Philadelphia area (FY 2024). NDRI ranks 14th on the list, which includes universities, health systems, and international pharmaceutical companies.

NDRI is proud to have received grant support from the NIH for more than 35 consecutive years.  In 2024, NDRI held 5 grants from the NIH, encompassing the Human Tissue and Organs for Research Resource (HTORR) Program, the Developmental Genotype-Tissue Expression Project (dGTEx), and the Somatic Mosaicism Across Human Tissues (SMaHT) Initiative. These programs are integral to NDRI’s mission, providing and collecting tissue for research, both to cure diseases and to understand human development.

The Philadelphia Business Journal Book of Lists is published annually. It ranks businesses and organizations in the Philadelphia Metro area according to revenue, head count, or other relevant metrics.

About NDRI

The National Disease Research Interchange (NDRI) is the nation’s leading source of human tissues, cells and organs for scientific research. A not-for-profit 501 (c) (3) organization founded in 1980, NDRI is funded in part by the National Institutes of Health, public and private foundations and organizations, pharmaceutical and biotechnology corporations. NDRI is a 24/7 operation that partners with a nationwide network of over 130 tissue source sites (TSS), including organ procurement organizations (OPOs), tissue banks, eye banks, and hospitals. The TSS, are distributed throughout the USA, in 45 states, with concentrations in major metropolitan areas on both the east and west coasts. Their wide geographic distribution allows NDRI to provide biospecimens from donor populations with diverse demographics and facilitates the timely and efficient provision of fresh tissues directly to researchers across the U.S. and around the world. By serving as the liaison between procurement sources and the research community, NDRI is uniquely positioned to support breakthrough advances and discoveries that can affect advances in the treatment and cure of human diseases.